Pilots’ body urges Air India, DGCA to pilot saliva drug tests after Phuket-Delhi incident
Following the Air India Phuket-Delhi incident and a reported positive marijuana test, the Federation of Indian Pilots has proposed a 12-month oral-fluid screening pilot, higher random-testing coverage and lab-confirmed results with medical review.
What happened
Following an Air India Phuket-Delhi incident and a reported positive marijuana test, pilots' federation FIP has asked DGCA to pilot saliva-based drug screening,
Key facts
- AI2379
- 300 feet altitude loss
- 17 people injured
- 45 minutes urine collection assumption
- 15 minutes oral-fluid collection assumption
- 66.7% potential workload reduction
- 10% current annual random-testing coverage
- 25% proposed annual random-testing coverage
- 12-month controlled pilot
Why this matters
Testing, diagnostics and occupational-health companies should assess partnerships with airlines and accredited labs as a 12-month saliva-testing pilot could establish a new aviation screening market.
What to watch
- DGCA circular, consultation paper or approval specifying a saliva-test pilot, eligible airports and testing protocol.
- Air India confirmation of changed random-testing coverage, testing vendor appointment or revised crew fitness policy.
- Publication of oral-fluid cutoff thresholds, lab accreditation requirements, chain-of-custody rules and medical-review process.
- Additional pilot impairment incidents or enforcement actions that increase political and regulatory urgency.
- Evidence of staffing disruption, higher sick/standby utilization or flight delays linked to expanded testing.
- Air India is likely to review vendor options for oral-fluid collection, lab confirmation, custody tracking and medical-review-officer services.
- Airlines may increase internal random-test frequency before any formal DGCA directive to demonstrate safety governance.
- Pilot unions and airline HR teams will negotiate privacy, prescription-medication disclosures, appeal procedures, removal-from-duty protocols and retesting standards.
- Testing-service providers, aviation medical contractors and accredited laboratories could see incremental demand if random coverage rises from 10% toward 25%.
- Carriers may tighten crew scheduling contingency plans because more immediate screenings can temporarily sideline personnel pending confirmatory results.